Contact Us
Drug Search Results
Using advanced filters...
Advanced Search [+]

FRAME-001

Alternative Names: frame-001, frame 001, frame001
Latest Update: 2024-01-01
Latest Update Note: PubMed Publication

Product Description

Frame Pharmaceuticals is a personalized vaccine for the treatment of patients with non-small cell lung cancer. (Sourced from: https://clinicaltrials.gov/ct2/show/NCT04998474?term=FRAME-001&draw=2&rank=1)

Mechanisms of Action: Vaccine

Novel Mechanism: No

Modality: Vaccine

Route of Administration: Subcutaneous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Frame Pharmaceuticals
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Non-Small-Cell Lung Cancer

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
FRAME-001

P2

Unknown status

Non-Small-Cell Lung Cancer

2024-01-01

FRAME-001

P2

Terminated

Non-Small-Cell Lung Cancer

2023-12-23

Recent News Events

Date

Type

Title

01/01/2024

PubMed

 A Review of Clinical Trials of Cancer and Its Treatment as a Vaccine.

07/21/2022

PubMed

 Development of a Personalized Tumor Neoantigen Based Vaccine Formulation (FRAME-001) for Use in a Phase II Trial for the Treatment of Advanced Non-Small Cell Lung Cancer.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions